
An experimental Ebola vaccine appeared effective in children and adults in a clinical trial. Two doses of Johnson & Johnson’s Ebola vaccine appear safe, well tolerated and produce a strong immune response in people over the age of 1, according to two just-published papers. The trial was conducted in the West African nation of Sierra… read on > read on >